PHACTR-1 (Phosphatase and Actin Regulator 1) Deficiency in Either Endothelial or Smooth Muscle Cells Does Not Predispose Mice to Nonatherosclerotic Arteriopathies in 3 Transgenic Mice
Authors:
- Sébastien RubinSRSébastien Rubin
- Pauline BougaranPBPauline Bougaran
- Alice AbelanetAAAlice Abelanet
- Valentin DelobelVDValentin Delobel
- Mathieu PernotMPMathieu Pernot
- Marie-Lise BatsMBMarie-Lise Bats
- Christian CombeCCChristian Combe
- Pascale DufourcqPDPascale Dufourcq
- Stéphanie DebetteSDStéphanie Debette
- Thierry CouffinhalTCThierry Couffinhal
- 1 May 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (5) , 597-609
Abstract
Background: Genome-wide association studies have revealed robust associations of common genetic polymorphisms in an intron of the PHACTR-1 (phosphatase and actin regulator 1) gene (chr6p24), with cervical artery dissection, spontaneous coronary artery dissection, and fibromuscular dysplasia. The aim was to assess its role in the pathogenesis of cervical artery dissection or fibromuscular dysplasia. Methods: Using various tissue-specific Cre-driver mouse lines, Phactr1 was deleted either in endothelial cells using 2 tissue-specific Cre-driver (PDGFB [platelet-derived growth factor B]-CreERT2 mice and Tie2 [tyrosine kinase with immunoglobulin and EGF homology domains]-Cre) and smooth muscle cells (smooth muscle actin-CreERT2) with a third tissue-specific Cre-driver. Results: To test the efficacy of the Phactr1 deletion after cre-induction, we confirmed first, a decrease in Phactr1 transcription and Phactr1 expression in endothelial cell and smooth muscle cell isolated from Phactr1iPDGFB and Phactr1iSMA mice. Irrespective to the tissue or the duration of the deletion, mice did not spontaneously display pathological phenotype or vascular impairment: mouse survival, growth, blood pressure, large vessel morphology, or actin organization were not different in knockout mice than their comparatives littermates. Challenging vascular function and repair either by angiotensin II–induced hypertension or limb ischemia did not lead to vascular morphology or function impairment in Phactr1-deleted mice. Similarly, there were no more consequences of Phactr1 deletion during embryogenesis in endothelial cells. Conclusions: Loss of PHACTR-1 function in the cells involved in vascular physiology does not appear to induce a pathological vascular phenotype. The in vivo effect of the intronic variation described in genome-wide association studies is unlikely to involve downregulation in PHACTR-1 expression.Keywords
This publication has 39 references indexed in Scilit:
- The ubiquitin ligase PDZRN3 is required for vascular morphogenesis through Wnt/planar cell polarity signallingNature Communications, 2014
- G-actin regulates the shuttling and PP1 binding of the RPEL protein Phactr1 to control actomyosin assemblyJournal of Cell Science, 2012
- Genome-wide association analysis identifies susceptibility loci for migraine without auraNature Genetics, 2012
- Neuropilin-1 regulates a new VEGF-induced gene, Phactr-1, which controls tubulogenesis and modulates lamellipodial dynamics in human endothelial cellsCellular Signalling, 2012
- Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial InfarctionCirculation, 2011
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- Efficient temporally‐controlled targeted mutagenesis in smooth muscle cells of the adult mouseGenesis, 2008
- Sex differences in the development of angiotensin II-induced hypertension in conscious miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Phactrs 1–4: A family of protein phosphatase 1 and actin regulatory proteinsProceedings of the National Academy of Sciences, 2004
- Tie2-Cre Transgenic Mice: A New Model for Endothelial Cell-Lineage Analysis in VivoDevelopmental Biology, 2001